Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hedera (HBAR) vs Injective (INJ) Price & Performance

Price performance (Past 24H)

Key statistics

Hedera vs Injective — how do they compare? Hedera trades at Rp1,163 (market cap Rp50,78T, Rp498,74M 24h volume), while Injective trades at Rp76,183 (market cap Rp7,62T, Rp1,22T 24h volume). The key difference: Hedera is far larger — about 6.7× Injective's market cap, and Hedera's supply is capped (43,8B / 50B HBAR (88%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Hedera for 56 Days and Injective for 37 Days on average.

HBARINJ
Market Cap
Rp50,78TRp7,62T
Volume (24h)
Rp498,74MRp1,22T
Circulating Supply
43,8B / 50B HBAR (88%)100M INJ
Typical Hold Time
56 Days37 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hedera

Hedera (HBAR) is currently trading at Rp1,178.64 with a bearish technical outlook, showing strong selling pressure in moving averages while oscillators remain neutral. The token is approaching its pivot point at Rp1,178 with immediate support at Rp1,165. With 88% of the 50 million max supply in circulation and average hold time of 56 days, the network maintains steady token distribution. No major protocol updates or ecosystem developments have been reported recently.

Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI levels suggest potential for short-term bounce. Key opportunities include network's enterprise adoption potential, while risks involve continued bearish momentum and crypto market volatility. Investors should monitor support levels closely for potential entry points.

Injective

Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.

The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HBAR
18% Buy82% Sell
Avg holding period · 56 Days
INJ
63% Buy37% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Hedera

Hedera (HBAR) is the most used, sustainable, enterprise-grade public network for the decentralized economy that allows individuals and businesses to create powerful decentralized applications (DApps). Hedera Hashgraph isn’t built on top of a conventional blockchain. Instead, it introduces a completely novel type of distributed ledger technology known as a Hashgraph. This technology allows it to improve upon many blockchain-based alternatives in several key areas, including speed, cost, and scalability.

Read more on HBAR

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ